| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:50 UTC |
|---|
| Update Date | 2022-03-07 02:51:45 UTC |
|---|
| HMDB ID | HMDB0014810 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Chlorpropamide |
|---|
| Description | Chlorpropamide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It belongs to the sulfonylurea class of insulin secretagogues, which act by stimulating I cells of the pancreas to release insulin. Sulfonylureas increase both basal insulin secretion and meal-stimulated insulin release. Medications in this class differ in their dose, rate of absorption, duration of action, route of elimination and binding site on their target pancreatic I cell receptor. Sulfonylureas also increase peripheral glucose utilization, decrease hepatic gluconeogenesis and may increase the number and sensitivity of insulin receptors. Sulfonylureas are associated with weight gain, though less so than insulin. Due to their mechanism of action, sulfonylureas may cause hypoglycemia and require consistent food intake to decrease this risk. The risk of hypoglycemia is increased in elderly, debilitated and malnourished individuals. Chlorpropamide is not recommended for the treatment of NIDDM as it increases blood pressure and the risk of retinopathy (UKPDS-33). Up to 80% of the single oral dose of chlorpropramide is metabolized, likely in the liver; 80-90% of the dose is excreted in urine as unchanged drug and metabolites. Renal and hepatic dysfunction may increase the risk of hypoglycemia. |
|---|
| Structure | CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1 InChI=1S/C10H13ClN2O3S/c1-2-7-12-10(14)13-17(15,16)9-5-3-8(11)4-6-9/h3-6H,2,7H2,1H3,(H2,12,13,14) |
|---|
| Synonyms | | Value | Source |
|---|
| 1-(p-Chlorobenzenesulfonyl)-3-propylurea | ChEBI | | 1-(p-Chlorophenylsulfonyl)-3-propylurea | ChEBI | | 1-Propyl-3-(p-chlorobenzenesulfonyl)urea | ChEBI | | 4-Chloro-N-((propylamino)carbonyl)benzenesulfonamide | ChEBI | | 4-Chloro-N-[(propylamino)carbonyl]benzenesulfonamide | ChEBI | | Chlorpropamidum | ChEBI | | Clorpropamida | ChEBI | | N-(4-Chlorophenylsulfonyl)-n'-propylurea | ChEBI | | N-(p-Chlorobenzenesulfonyl)-n'-propylurea | ChEBI | | N-Propyl-n'-(p-chlorobenzenesulfonyl)urea | ChEBI | | N-Propyl-n'-p-chlorophenylsulfonylcarbamide | ChEBI | | Diabinese | Kegg | | 1-(p-Chlorobenzenesulphonyl)-3-propylurea | Generator | | 1-(p-Chlorophenylsulphonyl)-3-propylurea | Generator | | 1-Propyl-3-(p-chlorobenzenesulphonyl)urea | Generator | | 4-Chloro-N-((propylamino)carbonyl)benzenesulphonamide | Generator | | 4-Chloro-N-[(propylamino)carbonyl]benzenesulphonamide | Generator | | N-(4-Chlorophenylsulphonyl)-n'-propylurea | Generator | | N-(p-Chlorobenzenesulphonyl)-n'-propylurea | Generator | | N-Propyl-n'-(p-chlorobenzenesulphonyl)urea | Generator | | N-Propyl-n'-p-chlorophenylsulphonylcarbamide | Generator | | Chlorporpamide | HMDB | | Apotex brand OF chlorpropamide | HMDB | | Farmasierra brand OF chlorpropamide | HMDB | | Insogen | HMDB | | Clorpropamid | HMDB | | Pfizer brand OF chlorpropamide | HMDB | | Apo-chlorpropamide | HMDB | | Byk gulden brand OF chlorpropamide | HMDB | | Glucamide | HMDB | | Meldian | HMDB |
|
|---|
| Chemical Formula | C10H13ClN2O3S |
|---|
| Average Molecular Weight | 276.74 |
|---|
| Monoisotopic Molecular Weight | 276.033540689 |
|---|
| IUPAC Name | 1-(4-chlorobenzenesulfonyl)-3-propylurea |
|---|
| Traditional Name | chlorpropamide |
|---|
| CAS Registry Number | 94-20-2 |
|---|
| SMILES | CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1 |
|---|
| InChI Identifier | InChI=1S/C10H13ClN2O3S/c1-2-7-12-10(14)13-17(15,16)9-5-3-8(11)4-6-9/h3-6H,2,7H2,1H3,(H2,12,13,14) |
|---|
| InChI Key | RKWGIWYCVPQPMF-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Benzenesulfonamides |
|---|
| Direct Parent | Benzenesulfonamides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Benzenesulfonamide
- Benzenesulfonyl group
- Chlorobenzene
- Halobenzene
- Sulfonylurea
- Aryl chloride
- Aryl halide
- Organic sulfonic acid or derivatives
- Organosulfonic acid or derivatives
- Sulfonyl
- Aminosulfonyl compound
- Carboximidic acid derivative
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Organic nitrogen compound
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Organopnictogen compound
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 127 - 129 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.16 g/L | Not Available | | LogP | 1.8 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 6.32 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 11.736 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.13 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1521.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 324.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 133.0 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 198.7 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 106.0 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 420.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 464.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 115.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 897.9 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 395.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1281.0 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 264.8 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 293.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 345.9 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 155.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 50.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Chlorpropamide,1TMS,isomer #1 | CCCN(C(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1)[Si](C)(C)C | 2240.7 | Semi standard non polar | 33892256 | | Chlorpropamide,1TMS,isomer #1 | CCCN(C(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1)[Si](C)(C)C | 2331.4 | Standard non polar | 33892256 | | Chlorpropamide,1TMS,isomer #1 | CCCN(C(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1)[Si](C)(C)C | 3146.6 | Standard polar | 33892256 | | Chlorpropamide,1TMS,isomer #2 | CCCNC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(Cl)C=C1 | 2224.8 | Semi standard non polar | 33892256 | | Chlorpropamide,1TMS,isomer #2 | CCCNC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(Cl)C=C1 | 2211.1 | Standard non polar | 33892256 | | Chlorpropamide,1TMS,isomer #2 | CCCNC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(Cl)C=C1 | 3175.9 | Standard polar | 33892256 | | Chlorpropamide,2TMS,isomer #1 | CCCN(C(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(Cl)C=C1)[Si](C)(C)C | 2184.8 | Semi standard non polar | 33892256 | | Chlorpropamide,2TMS,isomer #1 | CCCN(C(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(Cl)C=C1)[Si](C)(C)C | 2462.0 | Standard non polar | 33892256 | | Chlorpropamide,2TMS,isomer #1 | CCCN(C(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(Cl)C=C1)[Si](C)(C)C | 2867.2 | Standard polar | 33892256 | | Chlorpropamide,1TBDMS,isomer #1 | CCCN(C(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1)[Si](C)(C)C(C)(C)C | 2475.3 | Semi standard non polar | 33892256 | | Chlorpropamide,1TBDMS,isomer #1 | CCCN(C(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1)[Si](C)(C)C(C)(C)C | 2565.5 | Standard non polar | 33892256 | | Chlorpropamide,1TBDMS,isomer #1 | CCCN(C(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1)[Si](C)(C)C(C)(C)C | 3156.9 | Standard polar | 33892256 | | Chlorpropamide,1TBDMS,isomer #2 | CCCNC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(Cl)C=C1 | 2465.9 | Semi standard non polar | 33892256 | | Chlorpropamide,1TBDMS,isomer #2 | CCCNC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(Cl)C=C1 | 2454.0 | Standard non polar | 33892256 | | Chlorpropamide,1TBDMS,isomer #2 | CCCNC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(Cl)C=C1 | 3199.8 | Standard polar | 33892256 | | Chlorpropamide,2TBDMS,isomer #1 | CCCN(C(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(Cl)C=C1)[Si](C)(C)C(C)(C)C | 2703.0 | Semi standard non polar | 33892256 | | Chlorpropamide,2TBDMS,isomer #1 | CCCN(C(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(Cl)C=C1)[Si](C)(C)C(C)(C)C | 2933.2 | Standard non polar | 33892256 | | Chlorpropamide,2TBDMS,isomer #1 | CCCN(C(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(Cl)C=C1)[Si](C)(C)C(C)(C)C | 2971.5 | Standard polar | 33892256 |
|
|---|